Hireventra — executive search
Led by HireventraApplications closed

Fractional Chief Technology Officer (CTO), Medical Devices & MedTech

Medical Devices | MedTech | Healthcare Technology | Surgical Technologies | Diag📍 United States / EuropeRemote / Flexible, with strategic on-site executive engagements as required. · Fractional Executive | Remote with Strategic On-Site Engagements

$480,000–$650,000 Annualized Equivalent (Pro-Rated Based on Engagement Scope)

The application deadline has passed.

About the role

Location:
United States / Europe
Work arrangement:
Remote / Flexible, with strategic on-site executive engagements as required.
Employment type:
Fractional Executive | Remote with Strategic On-Site Engagements
Sector:
Medical Devices | MedTech | Healthcare Technology | Surgical Technologies | Diag
Reports to:
CEO / Board of Directors

Company overview

Confidential MedTech and medical device growth companies operating across the United States and Europe. These organizations are developing advanced medical technologies spanning surgical systems, diagnostic platforms, imaging solutions, optical technologies, and next-generation healthcare devices. With a focus on innovation, product advancement, and commercial expansion, these businesses are seeking experienced executive technology leadership to strengthen engineering capabilities, accelerate product development, and support long-term growth.

The opportunity

We are seeking an accomplished Fractional Chief Technology Officer (CTO) to provide strategic and operational technology leadership across medical device and MedTech businesses. Reporting directly to the CEO and Board of Directors, the successful executive will shape technology strategy, oversee multidisciplinary engineering functions, guide product architecture, and drive complex medical technology programs from early-stage development through design verification, validation, regulatory certification, manufacturing readiness, and commercialization. This opportunity is suited to a seasoned technology executive who combines deep engineering expertise, medical device development experience, regulatory knowledge, and commercial leadership.

Key responsibilities

  • Establish and execute technology roadmaps aligned with corporate strategy, product portfolios, and commercial objectives.
  • Provide executive leadership and oversight of multidisciplinary engineering teams across hardware, software, optical systems, imaging technologies, and product development.
  • Guide system architecture, technical specifications, platform development, and complex product integration.
  • Direct product development programs from concept and feasibility through prototyping, verification, validation, and commercialization.
  • Ensure engineering activities align with applicable medical device regulatory requirements, design controls, and quality management systems.
  • Strengthen design verification and validation strategies, technical documentation, risk management, and product performance standards.
  • Lead technology transitions into manufacturing readiness, market introduction, and commercial deployment.
  • Improve engineering processes, technical governance, development efficiency, and resource allocation.
  • Conduct technical due diligence covering technology platforms, intellectual property, product maturity, engineering risks, and development feasibility.
  • Advise CEOs, boards, investors, and executive leadership on technology investments, product priorities, strategic partnerships, acquisitions, and growth opportunities.

Candidate profile

  • 15+ years of professional experience in medical devices, MedTech, surgical technologies, optical systems, diagnostic platforms, or related technology industries.
  • Demonstrated executive leadership experience as a CTO, VP of Engineering, SVP of Technology, CEO, COO, or equivalent senior technical executive.
  • Proven track record of developing and commercializing complex medical device products.
  • Strong expertise in product architecture, systems engineering, and multidisciplinary product development.
  • Practical knowledge of medical device design controls, design verification, validation, and regulatory certification.
  • Experience leading engineering organizations and managing complex technical development programs.
  • Understanding of manufacturing transition, product commercialization, and market readiness.
  • Demonstrated ability to assess technical risks, development investments, and product feasibility.
  • Experience collaborating with executive leadership teams, boards, investors, and external technology partners.
  • Exceptional strategic judgment, executive communication, and decision-making capabilities.

Preferred qualifications

  • Previous experience serving as a fractional CTO, interim CTO, or strategic technology advisor.
  • Experience supporting multiple MedTech or medical device businesses through growth and commercialization.
  • Exposure to FDA and European medical device regulatory frameworks.
  • Experience with ISO 13485 quality management systems and medical device design control processes.
  • Background in advanced surgical technologies, medical imaging, optical systems, or diagnostic innovation.
  • Experience supporting venture-backed companies, private equity portfolios, or investor-led technology assessments.
  • Experience evaluating technology acquisitions, intellectual property portfolios, and strategic partnerships.

Compensation & benefits

  • Annualized compensation equivalent of $480,000–$650,000, pro-rated according to engagement scope and time commitment.
  • Potential performance-based incentives, subject to engagement structure.
  • Flexible remote executive working arrangement.
  • Strategic on-site engagements when required.
  • Opportunities to advise multiple high-growth MedTech and medical device businesses.
  • Direct engagement with CEOs, founders, boards, and investment stakeholders.
  • Significant influence over technology strategy, engineering direction, and commercialization.
  • Potential for expanded executive responsibilities as portfolio companies grow.